Regulation of protein complex partners as a compensatory mechanism in aneuploid tumors

Gökçe Senger1, Stefano Santaguida1,2, Martin H Schaefer1

  • 1Department of Experimental Oncology, IEO European Institute of Oncology IRCCS, Milan, Italy.

Elife
|May 16, 2022
PubMed

Insights

Aneuploidy, or chromosome imbalance, impacts tumor proteomes by altering protein expression. Tumors develop compensatory mechanisms to manage this imbalance, influencing patient survival.

Area of Science:

  • Cancer Biology
  • Genomics
  • Proteomics

Background:

  • Aneuploidy, a deviation from the normal chromosome number, is common in human cancers.
  • The precise role of aneuploidy in cancer progression and its impact on the proteome are not fully understood.

Purpose of the Study:

  • To investigate the proteomic consequences of whole-chromosome aneuploidies in human tumors.
  • To identify regulatory mechanisms tumors employ to cope with aneuploidy-induced stoichiometric imbalances.

Main Methods:

  • Integration of multi-omics data, including aneuploidy status, transcriptomics, and proteomics.
  • Analysis of hundreds of The Cancer Genome Atlas/Clinical Proteomic Tumor Analysis Consortium tumor samples.
  • Examination of protein co-abundance and complex stoichiometry in aneuploid tumors.

Main Results:

  • Aneuploidy leads to widespread expression changes, not only on aneuploid chromosomes but also on non-aneuploid ones.
  • Proteins from aneuploid chromosomes show co-abundance with their complex members, with tighter regulation for aggregation-prone proteins.
  • Cellular machinery complexes exhibit functional selection to maintain stoichiometric balance despite aneuploidy.

Conclusions:

  • Tumors utilize post-translational modifications to establish compensatory and functional maintenance mechanisms against aneuploidy.
  • The effectiveness of these mechanisms in managing stoichiometric imbalance correlates with protein degradation pathways and patient survival.

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.6K
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
36.2K
Anaphase Promoting Complex00:50

Anaphase Promoting Complex

The stepwise destruction of specific proteins is necessary for the progression and completion of the cell cycle. Such proteins are ubiquitinated by ubiquitin ligases and then subsequently destroyed by the proteasome. The SCF (Skp1/Cullin/F-box) and the anaphase-promoting complex (APC) are two important ubiquitin ligases involved in cell cycle progression. While SCF is active throughout the cell cycle, APC gets activated during metaphase to anaphase transition. Cdc20 or Cdh1 binds to APC and...
3.0K
Protein Complexes with Interchangeable Parts01:57

Protein Complexes with Interchangeable Parts

Groups of proteins may form a complex where each protein in this complex has a different role in the overall execution of the complex’s function. Often some of the proteins in the complex can be replaced by a closely related variant to give a complex that contains many of the same components yet is functionally distinct.
The SCF ubiquitin ligase is a protein complex of five individual proteins. This complex attaches ubiquitin to other target proteins to mark them for degradation. In order...
2.6K